Introduction
Percutaneous endoscopic gastrostomy (PEG) is the most accepted method of enteral nutrition in patients who are unable to feed adequately orally and require tube feeding for more than one month. Although PEG is more cost-effective and less invasive than surgical gastrostomies, 1, 2 it could be associated with several complications and even early death. [1] [2] [3] [4] [5] [6] Although PEG is not an emergency procedure, the reported overall early mortality rates (death within 30 days of PEG) range from 3.3% to 28%. 5, [7] [8] [9] [10] In contrast, a 30-day mortality rate of 0.4-9.0% has been reported following usual abdominal surgeries, including esophagectomy, gastrectomy, right hemicolectomy, low anterior resection, hepatectomy, pancreaticoduodenectomy and surgery for peritonitis. 11 Thus, there is significant mortality post-PEG. 1 Knowledge of the risk factors of early death is important not only to avoid procedure-related death, but also to equip patients referred for PEG with adequate information about the procedure. Several studies have reported various risk factors for early mortality after PEG, including serum albumin concentration, age and histories of aspiration and diabetes mellitus. 4, 5, 7, 10, [12] [13] [14] [15] [16] Further, many studies have demonstrated associations between abnormalities in various objective measures of nutritional status and increased operative morbidity and mortality. 17 However, it is not clear whether the degree of malnutrition and the time of referral for PEG influence survival. 18 Several predictive nutritional evaluation models, named as PNI, have been developed and validated in heterogeneous groups of postoperative patients. Onodera's PNI, calculated from serum albumin levels and peripheral lymphocyte count, reflects both the nutritional and immune status of the patient. 19 Recent studies demonstrated that this PNI is a significant prognostic indicator in patients with several tumors. [20] [21] [22] Previous studies have shown that it is important to provide nutritional support for 10-14 days prior to major surgery in patients with severe nutritional risk, even though this may result in the surgical procedure being delayed. 23 In PEG as well, preoperative nutritional support could minimize the inherent morbidity of the procedure and might overcome potential disadvantages, including prolongation of hospital stay and the associated increased cost of hospitalization. 17 In this study, we first retrospectively analyzed a series of 268 patients who underwent PEG at our hospital, to identify the risk factors associated with early mortality following PEG. We found that Onodera's PNI was the only nutritional factor that had predictive ability for procedure related death. Next, we prospectively assessed 152 consecutive patients who were assessed for eligibility for PEG at our hospital. We provided a nutritional assistance period of at least 10 days before PEG for patients with malnutrition according to Onodera's PNI, and assessed the efficacy of nutritional support before PEG on the incidence of early death after PEG.
Patients and methods

Patients
In Sapporo Shirakaba-dai Hospital which is a Sapporo Medical University affiliated hospital, patients with dysphagia of more than one month were considered for PEG, which term is slightly longer than both guidelines of ASPEN 24 and ESPEN. 25 However, patients in whom PEG placement could not be performed for technical reasons, patients with any contraindication to PEG, and patients with a bad prognosis (unlikely to survive beyond one month), were excluded. The first retrospective analysis was conducted at Sapporo Shirakaba-dai Hospital from January 2006 until April 2010, with 268 patients who underwent PEG. From the clinical and laboratory data, which were extracted from hospital electronic medical records, we analyzed the predictive factors associated with early death (within 30 days) after PEG using univariate and multivariate analyses. We assessed age, gender, serum albumin concentration, total lymphocyte count, nutritional index, history of therapy with prednisolone and proton pomp inhibitors (PPIs)/histamine-2 receptor blockers (H2RBs), co-morbidities of diabetes mellitus, aspiration pneumonia and anorexia. Nutritional status was assessed using Onodera's PNI, which is calculated using the formula: PNI ¼ (10 Â serum albumin concentration (g/dl)) þ (0.005 Â absolute lymphocyte count (per mm 3 )). 19 In the second study, we prospectively assessed 152 consecutive patients who were assessed for eligibility for PEG at Sapporo Shirakaba-dai Hospital between January 2011 and January 2014 (Figure 1 ). Based on the patients' Onodera's PNI values, they were divided them into two groups, PNI !37 or PNI <37. Patients with better nutritional status (PNI !37) underwent PEG without nutritional support. For those with poorer nutritional status (PNI <37), we scheduled a nutritional assistance period of more than 10 days before PEG. Nutrition was mainly supported by nasogastric enteral feeding and/or intravenous hyperalimentation. As PNI score !37 was not a goal of the nutritional intervention, the patients underwent PEG even if their scores were still under 37. We assessed the efficacy of nutritional support before PEG on the incidence of early death after PEG.
The procedure was mainly performed by the modified introducer method using the Seldinger PEG kit (24 Fr size, Covidien Japan, Tokyo, Japan). 6 Under propofol sedation, the anterior gastric wall was sutured to the abdominal wall before PEG.
6 Figure 1 . Participant flow through the second study. We prospectively assessed 152 patients who were undergoing PEG assessed for eligibility. According to Onodera's PNI, patients were divided two groups, PNI ! 37 (n ¼ 90) or PNI < 37 (n ¼ 62). For patients with PNI < 37, we supported nutrition more than 10 days before PEG. Several patients were excluded as technical reasons for PEG procedure, death and declination to participate in the study. Finally, 115 patients received PEG.
This study was approved by the institutional review board of Sapporo Shirakaba-dai Hospital. Written, informed consent was obtained from all patients and their families before they entered the study.
Statistical methods
The characteristics of patients in both the prospective study and patients in the retrospective study were assessed using Student's two-tailed t-test and Fisher's exact test, as appropriate. Survival probabilities were calculated using Kaplan-Meier survival curves and were compared using the log-rank test in both studies. Cox proportional-hazards regression analysis was used for analysis of the confounding risk factors of early mortality after PEG. Then, multivariate analysis was performed using a stepwise Cox proportional hazards model.
Receiver operating characteristic (ROC) curve analysis was performed to determine the optimum cut-off point of the gradient for each Onodera's PNI score in predicting early mortality after PEG.
The results are presented as means 6 SD for each sample. Pvalues of less than 0.05 were considered significant. All P-values and 95% confidence intervals (CI) presented in the tables were based on two-sided tests.
Results
The characteristics of patients
The characteristics of patients in both studies, the first retrospective cohort and the second prospective cohort, are shown in Table 1 . No differences were found in age, gender and indication for PEG between the first cohort and both the number of patients in the second cohort who were initially scheduled for PEG and those who finally underwent PEG. On the other hand, although the number of patients with poor nutritional status (PNI <37) was larger in the second as compared with the first cohort (P < 0.001), the number of poor nutritional status patients who underwent PEG in the second cohort was not significantly different from that in the first cohort.
The first retrospective study Kaplan-Meier survival curve analysis of the 268 patients in the retrospective cohort indicated an early mortality rate of 5.2% (Figure 2 ). Mean survival time after PEG in the first cohort was 801 days (95% CI ¼ 585-968).
ROC curve analysis of patients in the first study was used to estimate the optimum cutoff point of Onodera's PNI score in predicting early death after PEG. The optimum cut-off point of PNI for prediction of early mortality was 36.670, with a specificity of 0.787 and sensitivity of 0.500. Thus, a cut-off PNI value of 37 was used to divide patients in the subsequent studies into poor and non-poor nutritional status groups.
In univariate analyses of factors predicting early mortality after PEG in the first cohort, low serum albumin concentration, history of therapy with prednisolone, and that with PPIs/H2RBs tended to increase the risk of early death, although the difference was not statistically significant ( Table 2 ). Only a PNI of less than 37 was associated with a significant risk of death within 30 days (HR ¼ 3.18, 95% CI 1.11-9.05, P ¼ 0.031). Multivariate analysis using a stepwise Cox proportional hazards model also indicated that only PNI was a significant prognostic variable for early death after PEG (HR ¼ 3.17, 95% CI 1.11-9.11, P ¼ 0.032, Table 3 ). This indicates that PNI is a useful prognostic marker for patients undergoing PEG.
In the first cohort, although there were no differences between the two nutritional status groups in terms of the final probability of survival (Figure 2b ), early mortality rate in the poor nutrition group was significantly higher than in the better group (P ¼ 0.0223, Figure 2c ).
The second prospective study
Hence, we provided nutritional support for at least 10 days for patients with a PNI of <37 in the second cohort. We prospectively investigated 152 patients who were assessed for eligibility for PEG (Figure 1 ). After assessment of PNI, patients were divided into two groups, PNI !37 (n ¼ 90) and PNI <37 (n ¼ 62). However, patients in whom PEG placement could not be performed for technical reasons, patients with any contraindication to PEG, and those who declined to participate in the study, were subsequently excluded. In the better nutrition group, 79 patients The early mortality rate after PEG in the second study was 1.7%, which was better than that in the first study, although the improvement did not achieve statistical significance (Figure 3a) . In the second study, there were no differences in 30-day mortality after PEG between the two groups divided according to PNI (Figure 3b) . Two patients died within 30 days after PEG, both of whom were in the better nutrition group. This might indicate that patients with malnutrition can also safely undergo PEG if they receive nutritional support preoperatively.
In addition, the prognosis of patients in the poor nutrition group who did not receive PEG was not good and 32% of the patients died within 30 days (Figure 3c ). It might be speculated that the relatively high early mortality rate following PEG in former reports might have been because of the inclusion of a significant number of patients with poor nutrition.
Complications and causes of death
There was neither trouble in bleeding or sedation. As we have reported previously, 2 several infectious diseases were occurred, including wound infection, pneumonia, urinary tract infection and sepsis. Major complications and causes of death were summarized in Supplementary Table 1 . In the first retrospectitve cohort, there was not any Grade III to V complication in ClavienDindo Classification besides pneumonia. In the second prospective cohort, Grade III of stomach perforation occurred during modified introducer method of PEG in one patient, who was transferred to surgery and finally received surgical gastrostomy. Thus this case was categorized as 'canceled' in PNI < 37 group.
Discussion
PEG is believed to be a safe and easy procedure for establishing a stable enteral nutrition route. However, the reported rates of early death after PEG are higher than those following other abdominal surgeries. One reason for this might be that the patients who need enteral feeding usually have a poor nutritional condition. Another possible reason is that these patients usually have one or more severe underlying diseases. Although investigators have attempted to delineate factors that might predict early postprocedure death in order to stratify patients referred for PEG, general consensus has not been reached as yet. Thus, we assessed markers predicting early death after PEG in our first study. With both univariate and multivariate analyses, Onodera's PNI of <37 was the only risk factor for early death after PEG. This PNI is scored on the basis of two factors, albumin concentration and lymphocyte count, both of which are used as factors reflecting nutritional status and were identified as risk factors for morbidity and early death after PEG in former studies. 4, 10, [12] [13] [14] [15] [16] Several studies concluded that the nutritional status of patients before PEG might influence mortality. 16 Hypoalbuminemia and lymphocytopenia are reportedly related to an increased risk of postoperative complications and higher mortality during follow up. 16 Thus, Onodera's PNI might be a candidate risk factor for early mortality after PEG. An advantage of using this index for predicting the prognosis after PEG is that both albumin concentration and lymphocyte counts are usually examined routinely, especially at the time of admission, making this index easy to calculate. After the nutritional support period for patients with malnutrition, the number of patients whose PNI had become !37 was not high in this study. However, those patients underwent PEG did not die within 30 days. It might be speculated that several attempts to support nutritionally is important for the patients with malnutrition. In addition, the score of PNI <37 might be a predictive factor for early mortality after PEG, however it would not mean a contraindication for this procedure.
A wait period or a cooling time was proposed as a strategy to prevent early mortality after PEG. 26, 27 The hospital with a oneweek waiting policy inserted fewer PEGs, but had a lower early mortality rate compared with the hospital without this policy. 26 There were seven deaths (17.5%) within eight days in patients who did not undergo PEG in the hospital with a waiting policy. This is similar to our results and indicates that a significant number of patients might die prior to PEG after a referral is made. It is desirable that both patient selection and timing for PEG are guided by prognostic factors for mortality. 27 A wait period with nutritional support for approximately 1-2 weeks, especially for patients with PNI <37, might reduce post-PEG death and result in cost saving. As PEG might force several stress for patients with malnutrition, who might be unable to tolerate this procedure without some preoperative nutritional assistance. Thus the early mortality rates after PEG might be high in the previous reports and our first retrospective study. If patients, who had speculated to need enteral nutrition over a few weeks, died within 30 days after PEG, the indication for PEG should be verified by both patient's comforts and social costs.
Our study has certain limitations and positive features that require mention. The current study was performed at a single institution and included only few patients with surgically treated malignant tumors, which is a plus point of our study. A limitation of this study is that it included only a small number of patients. In order to confirm our results more precisely, additional investigations in a larger-scale, multicenter study will be needed. Further, our study design was observational and did not allow for randomization or blinding, which could lead to bias. Moreover, some learning effects from the first study might be a bias for the second study. Since 2009, we performed computed tomography just after endoscopy as the preoperative examination, 2 which might affect as another bias for the prospective study.
In conclusion, nutritional status, especially Onodera's PNI <37, might be a predictive factor for early mortality after PEG. Preoperative nutritional support period for patients with poor nutritional status might improve the results of this procedure and might reduce unnecessary PEG. Further prospective studies with large-scale in multicenter will be needed to be clarify this conclusion.
